However, some studies have suggested that compensatory upregulation of CDH1 gene expression may occur in the early stages of certain cancers (20), potentially as an adaptive response by cancer cells to maintain a degree of cell adhesion, specific to the tumor microenvironment or cancer progression stage. This evidence concerns the gene CDH1 and neoplasm.